New and recently funded Medical Startups
1
Country: Brazil | Funding: $42M
Telepatia offers an AI platform for healthcare providers. It includes AI documentation, clinical decision support and a suite of healthcare employees, including AI doctors, nurses and auditors. The AI is trained on peer-reviewed literature, clinical guidelines and local institutional protocols in Latin America. Telepatia is already deployed across 25+ hospitals and basing on own statistics, improves protocol adherence from 84% to 99%.
Telepatia offers an AI platform for healthcare providers. It includes AI documentation, clinical decision support and a suite of healthcare employees, including AI doctors, nurses and auditors. The AI is trained on peer-reviewed literature, clinical guidelines and local institutional protocols in Latin America. Telepatia is already deployed across 25+ hospitals and basing on own statistics, improves protocol adherence from 84% to 99%.
2
Country: France | Funding: $165M
Bionyra advances antibodies aimed at diseases with unmet need despite currently available treatments, including atopic dermatitis and inflammatory bowel disease (IBD). In particular, Bionyra licensed the ex-China rights to BYN-001 from New Jersey-based NovaRock Biotherapeutics. The monoclonal antibody targets the IL-25 pathway, has half-life extension (HLE) technology and is at the IND filing stage for atopic dermatitis, according to the company.
Bionyra advances antibodies aimed at diseases with unmet need despite currently available treatments, including atopic dermatitis and inflammatory bowel disease (IBD). In particular, Bionyra licensed the ex-China rights to BYN-001 from New Jersey-based NovaRock Biotherapeutics. The monoclonal antibody targets the IL-25 pathway, has half-life extension (HLE) technology and is at the IND filing stage for atopic dermatitis, according to the company.
3
Country: USA | Funding: $181.6M
Phil is a B2B2C platform that provides end-to-end prescription management and delivery service.
Phil is a B2B2C platform that provides end-to-end prescription management and delivery service.
4
Country: USA | Funding: $112.3M
Solera allows health plans and employers to securely and efficiently leverage a network of community and digital health solutions.
Solera allows health plans and employers to securely and efficiently leverage a network of community and digital health solutions.
5
Country: USA | Funding: $375K
Melior Pharmaceuticals is a clinical stage pharmaceutical company developing treatment for metabolic disease and skin disorders.
Melior Pharmaceuticals is a clinical stage pharmaceutical company developing treatment for metabolic disease and skin disorders.
6
Country: USA | Funding: $65.4M
Jawbone Health is a personalized subscription service that utilizes continuous health information combined with human and machine intelligence to take care of its members on a daily basis.
Jawbone Health is a personalized subscription service that utilizes continuous health information combined with human and machine intelligence to take care of its members on a daily basis.
7
Country: USA | Funding: $35M
Prosper AI utilizes AI voice agents to automate tasks like patient visit scheduling, phone calls and eligibility verification.
Prosper AI utilizes AI voice agents to automate tasks like patient visit scheduling, phone calls and eligibility verification.
8
Country: USA | Funding: $36M
Neuraly is a Johns Hopkins School of Medicine spinoff biotech company and aims to introduce the first, disease-modifying agent for neurodegenerative disorders and aging.
Neuraly is a Johns Hopkins School of Medicine spinoff biotech company and aims to introduce the first, disease-modifying agent for neurodegenerative disorders and aging.
9
Country: USA | Funding: $81.7M
Aridis is a biopharmaceutical company focused on the development of human antibodies for hospital-related infections
Aridis is a biopharmaceutical company focused on the development of human antibodies for hospital-related infections
10
Country: Austria
Heart Regeneration Technologies develops low-energy regenerative shockwave therapy for regeneration of infarcted heart muscle.
Heart Regeneration Technologies develops low-energy regenerative shockwave therapy for regeneration of infarcted heart muscle.
